TABLE 3.
Medication use by Global Registry of Acute Coronary Events (GRACE) risk groups
| Treatment within first 24 h | Overall (n=7131), % |
GRACE risk group (score) |
P (for trend) | ||
|---|---|---|---|---|---|
| Low (≤108) (n=2589), % | Intermediate (109–140) (n=2236), % | High (≥141) (n=2306), % | |||
| Acetylsalicylic acid | 91.2 | 94.5 | 91.9 | 86.8 | <0.001 |
| Thienopyridine | 58.7 | 63.4 | 61.5 | 50.7 | <0.001 |
| Unfractionated heparin | 28.4 | 25.2 | 29.4 | 31.1 | <0.001 |
| Low molecular weight heparin | 62.5 | 69.1 | 62.3 | 55.2 | <0.001 |
| Glycoprotein IIb/IIIa inhibitor | 7.0 | 7.5 | 8.1 | 5.2 | 0.003 |
| Angiotensin-converting enzyme inhibitor | 55.3 | 54.6 | 56.0 | 55.5 | 0.52 |
| Beta-blocker | 77.7 | 82.0 | 78.4 | 72.2 | <0.001 |
| Angiotensin receptor blocker | 10.8 | 8.7 | 12.4 | 11.7 | 0.001 |
| Calcium channel blocker | 25.6 | 20.4 | 25.9 | 31.3 | <0.001 |
| Statin | 65.5 | 68.2 | 67.4 | 60.5 | <0.001 |